Core Viewpoint - The company has approved the use of idle raised funds for cash management, ensuring that it does not affect the progress of investment projects and fund safety [2][5]. Group 1: Announcement of Fund Management - The company has opened a dedicated settlement account for financial products using raised funds, which will only be used for purchasing financial products and will not hold non-raised funds [3]. - The board has authorized the chairman or designated individuals to make investment decisions regarding cash management and sign relevant legal documents [2]. Group 2: Risk Control Measures - The company will strictly adhere to relevant laws and regulations, and will monitor the operation of cash investment products, taking timely measures to control investment risks if adverse factors are identified [4]. - Independent directors and the supervisory board have the right to supervise and inspect the company's fund usage and cash management [4]. Group 3: Impact on the Company - The use of idle raised funds for cash management is aimed at improving the efficiency of fund usage and generating investment returns, ultimately benefiting shareholders [5].

Core Viewpoint - The company has announced the establishment of a dedicated settlement account for financial products, allowing the use of temporarily idle raised funds for cash management, ensuring the safety of funds and the progress of investment projects [2][3]. Group 1: Financial Management - The company approved a proposal to use up to RMB 450 million of raised funds for cash management, focusing on high-security, liquid, and capital-preserving financial products [2]. - A dedicated settlement account for financial products has been opened with Guotai Junan Securities, specifically for the settlement of temporarily idle raised funds [2]. Group 2: Risk Control Measures - The company will adhere to relevant regulations and internal policies for cash management, with independent directors and the supervisory board having the authority to oversee fund usage [3]. - The company will analyze and monitor the performance of cash investment products and take timely measures to control investment risks if adverse factors are identified [3]. Group 3: Impact on the Company - The use of excess and temporarily idle raised funds for cash management will not affect the funding turnover and needs of the company's investment projects, thereby improving the efficiency of fund usage and potentially increasing overall performance [3].

| 证券代码：688292 | 证券简称：浩瀚深度 | 公告编号：2025-040 | | --- | --- | --- | | 转债代码：118052 | 转债简称：浩瀚转债 | | 北京浩瀚深度信息技术股份有限公司 关于开立理财产品专用结算账户的公告 三、对公司的影响 公司是在确保募投项目建设进度和资金安全的前提下，使用超募资金及部分 闲置募集资金进行现金管理，不影响公司募投项目的资金周转和需要。通过适当 现金管理，可以提高募集资金的使用效率，获得一定的投资收益，提高公司的整 体业绩水平，为公司股东谋求更多的投资回报，符合公司及全体股东的利益。 近日，公司开立了募集资金理财产品专用结算账户，具体信息如下： | 国泰海通证券股份 | 国泰海通证券北京中 | 北京浩瀚深度信息 | 11100071026892 | | --- | --- | --- | --- | | 开户机构 有限公司 | 开户地址 关村南大街营业部 | 开户名称 技术股份有限公司 | 资金账号 | 根据《上市公司募集资金监管规则》的相关规定，公司将在理财产品到期且 无下一步购买计划时及时注销以上专户。上述账户将专用于暂时闲置募集资金购 ...

Group 1: Haohan Depth - Haohan Convertible Bond (118052) is set to be listed on April 7, 2025 [1] - The company's subsidiary, Nanjing Youzhu Information Technology Co., Ltd., has established a "Low-altitude Airspace Safety Technology Innovation Joint Laboratory" in collaboration with China Telecom Design Institute, Nanjing University, and Jinling Institute of Technology [1] - The company's DPI technology and related cybersecurity solutions are designed to identify risks, recognize threats, block attacks, and protect data and privacy, effectively ensuring overall security in the Internet of Vehicles, including vehicle-side, roadside, cloud-side, and platform security [1] Group 2: Xingye Silver Tin - The recent research involved the progress of Yinman Phase II, the expansion of Yubang Mining, the injection arrangement of Budun Silver Mine, and the company's development strategy [1] - Yinman Phase II has received project approval and is in communication with the government for construction permits; Yubang Mining's 8.25 million ton expansion project is applying for construction permits [1] - The company focuses on silver and tin as core businesses while steadily integrating copper and gold resources; the Yubang Mining expansion project is expected to produce 450 tons of silver annually upon reaching full capacity [1] - The company has established a comprehensive safety management system, emphasizing safety funding investment and promoting mechanization, automation, informationization, and intelligence construction [1] - The mining areas of Yinman and Yubang show promising mineralization, with good exploration prospects for the Morocco project [1]

Group 1 - Yabont Chemical signed a 10-year supply strategic agreement with Jiangsu Hengrui Medicine to enhance collaboration in the pharmaceutical supply chain, effective from August 1, 2025 [1] - Wei Hua New Materials plans to acquire controlling interest in Jiangsu Heyutai Chemical to extend its product chain and improve competitiveness, currently in the planning stage [2] - Fujirey received a government subsidy of 2.0074 million yuan, expected to positively impact profits in 2025 [4] Group 2 - Hangzhou Garden won the land use rights for a plot in Yuhang District for 130 million yuan, planning to build a smart ecological design R&D headquarters with a total investment of no more than 450 million yuan [5] - Baotai's clinical trial for BAT5906, a recombinant anti-VEGF monoclonal antibody, received approval for new indications, aiming to accelerate commercialization [6] - Weisheng Information won multiple projects with a total bid amount of 110 million yuan, including significant contracts with Southern Power Grid and State Grid [8] Group 3 - Dong'an Power reported a 27.37% year-on-year increase in engine sales for July, totaling 34,500 units [13] - Hanma Technology's truck sales reached 956 units in July, marking a 42.69% year-on-year increase [14] - Jiangsu Bank's executives received regulatory approval for their positions, effective immediately [15] Group 4 - Chip Origin expects Q2 revenue of 584 million yuan, a 49.90% increase quarter-on-quarter, with significant growth in intellectual property licensing fees [24] - Dream Network Technology plans to establish a high-end equipment industry investment fund with a target fundraising of 2 billion yuan [26] - Hefei Urban Construction and China Real Estate Development won land use rights for a residential plot in Hefei for 980 million yuan [28] Group 5 - Lu Kang Pharmaceutical's subsidiary received a drug registration certificate for a new medication for erectile dysfunction [28] - Lifan Pharmaceutical's Mesalazine enteric-coated tablets received a drug registration certificate for treating ulcerative colitis [29] - Yahu Pharmaceutical's APL-1401 clinical trial for ulcerative colitis showed positive preliminary results [30]

Core Viewpoint - The major shareholder of Beijing Haohan Deep Information Technology Co., Ltd. plans to reduce its stake in the company due to personal funding needs, which may impact the stock's market performance and investor sentiment [3][12]. Shareholder Information - As of the announcement date, the major shareholder, Shanghai Lianchuang Yongqin Venture Capital Enterprise (Limited Partnership), holds 9,775,231 shares, accounting for 6.1733% of the total share capital [2]. - The shares held by the major shareholder were obtained prior to the company's initial public offering and became tradable on August 18, 2023 [2]. Reduction Plan Details - The shareholder plans to reduce a total of up to 3,441,397 shares, which is not more than 2.1733% of the company's total share capital, through centralized bidding and/or block trading [3]. - The reduction period is set to begin 15 trading days after the announcement and will last for three months, from August 22, 2025, to November 21, 2025 [3]. Shareholder Commitments - The major shareholder has made commitments regarding shareholding, including a lock-up period of 12 months post-IPO during which they will not transfer or manage their shares [5][6]. - The shareholder will not reduce their holdings under certain conditions, such as during investigations by regulatory authorities or if the company is facing significant legal issues [6][7]. Compliance and Legal Obligations - The shareholder has committed to adhering to relevant laws and regulations regarding share reduction, including timely disclosures of any reduction plans [9][10]. - Any failure to comply with these commitments may result in legal liabilities for the shareholder [10]. Impact on Company - The planned reduction is based on the shareholder's personal funding needs and is not expected to significantly affect the company's governance structure or ongoing operations [12].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688292 证券简称：浩瀚深度 公告编号：2025-039 转债代码：118052 转债简称：浩瀚转债 北京浩瀚深度信息技术股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 大股东持股的基本情况 截至本公告披露之日，北京浩瀚深度信息技术股份有限公司（以下简称"公司"）股东上海联创永钦创业 投资企业（有限合伙）（以下简称"联创永钦"）持有公司无限售流通股份9,775,231股，占公司总股本比 例为6.1733%，上述股份来源于公司首次公开发行前持有的股份，已于2023年8月18日上市流通。 ● 减持计划的主要内容 因自身资金需求，股东联创永钦计划通过集中竞价和/或大宗交易的方式，合计减持不超过其持有的公 司股份3,441,397股，即不超过公司总股本的2.1733%。若减持期间公司有送股、资本公积转增股本等股 份变动事项，减持股份数量将进行相应的调整。本次减持计划期间为自本公告披露之日起15个交易日后 ...

Group 1: Artificial Intelligence Initiatives - The State Council approved the "Artificial Intelligence +" action plan to promote large-scale commercial applications of AI, leveraging China's complete industrial system and large market scale [1] - The National Development and Reform Commission emphasized the need to deepen the "Artificial Intelligence +" initiative and promote high-quality development of the low-altitude economy [2] - The National Medical Insurance Administration supports the clinical application and pricing of new technologies like brain-computer interfaces, establishing pricing for related medical services [2] Group 2: Corporate Developments - Tesla expanded its Robotaxi service to the California Bay Area, covering cities from San Francisco to San Jose [4] - Dongxin Co. clarified that its products are not used in large model computing clusters, indicating potential risks due to rapid stock price increases [5] - Dingtong Technology's major shareholder plans to transfer 3% of the company's shares due to personal funding needs [5] Group 3: Clinical Trials and Approvals - Yahui Pharmaceutical reported positive preliminary results from its Phase Ib clinical trial for APL-1401, aimed at treating moderate to severe ulcerative colitis [5] - Micron Biotech received FDA approval for a Phase I clinical trial of CS231295, a selective AuroraB inhibitor for treating advanced solid tumors [6] - ST Norate obtained drug registration certificates for two new products, indicating expansion in reproductive and mental health sectors [7] Group 4: Financing and Investments - "Zero Degree Robotics" completed two rounds of financing totaling over 100 million yuan, focusing on technology development and production acceleration [10] - Puliyan Medical completed nearly $50 million in Series C financing to enhance product development and market expansion [11]

【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不 对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担 全部责任。邮箱：news_center@staff.hexun.com 智通财经APP讯，浩瀚深度(688292.SH)发布公告，因自身资金需求，股东联创永钦计划通过集中竞价 和/或大宗交易的方式，合计减持不超过其持有的公司股份344.14万股，即不超过公司总股本的 2.1733%。 ...

Core Viewpoint - The shareholder Lianchuang Yongqin plans to reduce its holdings in Haohan Deep (688292.SH) due to its own funding needs, with a total reduction of up to 3.4414 million shares, representing no more than 2.1733% of the company's total share capital [1] Summary by Relevant Sections - **Shareholder Reduction Plan** - Lianchuang Yongqin intends to reduce its stake through centralized bidding and/or block trading [1] - The reduction period is set for three months starting from 15 trading days after the announcement, specifically from August 22, 2025, to November 21, 2025 [1] - **Adjustment Clause** - The number of shares to be reduced will be adjusted accordingly if there are changes in the number of shares due to stock dividends or capital reserve transfers during the reduction period [1]